IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

China SXT Pharmaceuticals in (SXTC)

CUSIP: G2161P132 | Healthcare · Drug Manufacturers - Specialty & Generic | Micro Cap | 15 institutional holders

Quarters

Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2023

Citadel Advisors LLC191,339
0.0% of portfolio›$23.5K
Acadian Asset Management LLC105,039
0.0% of portfolio›$12
Two Sigma Securities, LLC49,965
0.0% of portfolio›$6.1K
HRT Financial LP48,507
0.0% of portfolio›$5
Level Four Advisory Services, LLC42,771
0.0% of portfolio›$5.3K
UBS Group AG29,870
0.0% of portfolio›$3.7K
Baader Bank Aktiengesellschaft12,916
0.0% of portfolio›$1.4K
Qube Research & Technologies Ltd50
0.0% of portfolio›$6
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Citadel Advisors LLC
191,339$23.5K0.0%CoreVery HighMiami, FL2023-11-14
Acadian Asset Management LLC
105,039$120.0%GARPMediumBoston, MA2023-11-13
Two Sigma Securities, LLC
49,965$6.1K0.0%ValueVery HighNew York, NY2023-11-14
HRT Financial LP
48,507$50.0%GARPVery HighNew York, NY2023-11-13
Level Four Advisory Services, LLC
42,771$5.3K0.0%CoreLowDallas, TX2023-11-13
UBS Group AG
29,870$3.7K0.0%CoreMediumZurich, Switzerland2023-11-09
Baader Bank Aktiengesellschaft
12,916$1.4K0.0%CoreHighUnterschleissheim, Hong Kong2023-11-14
Qube Research & Technologies Ltd
50$60.0%ValueVery HighLondon, United Kingdom2023-11-13
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2023-10-30